Drugs that contain Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride
1. Zyrtec-d 12 Hour patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6489329 | J AND J CONSUMER INC | Pharmaceutical compositions for the treatment of rhinitis |
Apr, 2016
(8 years ago) | |
| US6469009 | J AND J CONSUMER INC | Pharmaceutical compositions for the treatment of rhinitis |
Jul, 2019
(4 years ago) | |
| US7226614 | J AND J CONSUMER INC | Tablet comprising cetirizine and pseudoephedrine |
Jun, 2022
(1 year, 10 months ago) | |
| US7014867 | J AND J CONSUMER INC | Tablet comprising cetirizine and pseudoephedrine |
Jun, 2022
(1 year, 10 months ago) | |
Market Authorisation Date: 09 November, 2007
Treatment: Treatment of seasonal and perennial allergic rhinitis symptoms
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of ZYRTEC-D 12 HOUR before it's drug patent expiration?
More Information on Dosage
ZYRTEC-D 12 HOUR family patents
